Kyle C. Roche

1.9k total citations · 1 hit paper
20 papers, 1.6k citations indexed

About

Kyle C. Roche is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Kyle C. Roche has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Immunology and 7 papers in Biomedical Engineering. Recurrent topics in Kyle C. Roche's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Kyle C. Roche is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Kyle C. Roche collaborates with scholars based in United States, China and Japan. Kyle C. Roche's co-authors include Andrew Z. Wang, Benjamin G. Vincent, Jonathan S. Serody, Joseph M. Caster, Yuanzeng Min, Joel E. Tepper, Tian Zhang, Laura E. Herring, Longzhen Zhang and Michael J. Eblan and has published in prestigious journals such as Advanced Materials, ACS Nano and Gastroenterology.

In The Last Decade

Kyle C. Roche

19 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

2017 590 citations Yuanzeng Min, Kyle C. Roche et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kyle C. Roche United States	14	828	556	550	540	410	20	1.6k
Yixin Wang United States	19	722 0.9×	462 0.8×	776 1.4×	337 0.6×	283 0.7×	40	1.8k
Sara Musetti United States	12	821 1.0×	547 1.0×	599 1.1×	396 0.7×	526 1.3×	15	1.6k
Xiuwen Guan China	18	871 1.1×	585 1.1×	727 1.3×	502 0.9×	475 1.2×	30	1.9k
Ashish Kulkarni United States	24	702 0.8×	696 1.3×	674 1.2×	306 0.6×	275 0.7×	56	1.7k
Hao Qin China	19	891 1.1×	437 0.8×	810 1.5×	404 0.7×	576 1.4×	34	1.9k
Xinghui Si China	19	622 0.8×	470 0.8×	386 0.7×	259 0.5×	346 0.8×	37	1.2k
Youshi Zheng China	23	673 0.8×	452 0.8×	565 1.0×	281 0.5×	203 0.5×	43	1.4k
Neha N. Parayath United States	19	555 0.7×	620 1.1×	927 1.7×	457 0.8×	386 0.9×	29	1.8k
Ying‐Li Luo China	22	625 0.8×	440 0.8×	1.1k 2.0×	256 0.5×	407 1.0×	37	1.9k
Junhua Mai United States	25	595 0.7×	554 1.0×	1.1k 2.0×	534 1.0×	472 1.2×	58	2.1k

Countries citing papers authored by Kyle C. Roche

Since Specialization

Citations

This map shows the geographic impact of Kyle C. Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle C. Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle C. Roche more than expected).

Fields of papers citing papers by Kyle C. Roche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle C. Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle C. Roche. The network helps show where Kyle C. Roche may publish in the future.

Co-authorship network of co-authors of Kyle C. Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle C. Roche. A scholar is included among the top collaborators of Kyle C. Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle C. Roche. Kyle C. Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miura, Kazutoyo, Bingbing Deng, Thao Pham, et al.. (2024). A human-serum-free medium can induce more infectious P. falciparum gametocytes than a conventional human-serum-containing medium. Scientific Reports. 14(1). 22052–22052.

Li, Rui, et al.. (2023). Chemotherapy-induced nanovaccines implement immunogenicity equivalence for improving cancer chemoimmunotherapy. Biomaterials. 301. 122290–122290. 15 indexed citations

Deng, Bingbing, et al.. (2023). Mesenchymal stem cells of the bone marrow raise infectivity of Plasmodium falciparum gametocytes. mBio. 14(6). e0223223–e0223223. 2 indexed citations

Li, Rui, et al.. (2023). Chemotherapy-Induced Neoantigen Nanovaccines Enhance Checkpoint Blockade Cancer Immunotherapy. ACS Nano. 17(19). 18818–18831. 13 indexed citations

DeRosa, Peter, Kyle C. Roche, Victor E. Nava, et al.. (2022). Concurrent Waldenstrom’s Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation. Current Oncology. 29(7). 4587–4592. 1 indexed citations

Hagan, C. Tilden, Xi Tian, Feifei Yang, et al.. (2021). Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models. Acta Biomaterialia. 124. 327–335. 54 indexed citations

Moufarrij, Sara, Aneil Srivastava, Stephanie Gomez, et al.. (2020). Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer. Scientific Reports. 10(1). 3470–3470. 73 indexed citations

Zhang, Longzhen, Yuanzeng Min, Joseph M. DeSimone, et al.. (2020). Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. UNC Libraries. 7 indexed citations

Tian, Xi, Michael E. Werner, Kyle C. Roche, et al.. (2018). Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds. Nature Biomedical Engineering. 2(6). 443–452. 84 indexed citations

10.

Hagan, C. Tilden, Xi Tian, Feifei Yang, et al.. (2018). Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models. Biomaterials. 169. 1–10. 70 indexed citations

11.

Mi, Yu, Christof C. Smith, Feifei Yang, et al.. (2018). A Dual Immunotherapy Nanoparticle Improves T‐Cell Activation and Cancer Immunotherapy. Advanced Materials. 30(25). e1706098–e1706098. 175 indexed citations

12.

Mi, Yu, Christof C. Smith, Feifei Yang, et al.. (2018). Combination Immunotherapy: A Dual Immunotherapy Nanoparticle Improves T‐Cell Activation and Cancer Immunotherapy (Adv. Mater. 25/2018). Advanced Materials. 30(25). 5 indexed citations

13.

Tian, Jing, Yuanzeng Min, Zachary L. Rodgers, et al.. (2017). Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models. Journal of Materials Chemistry B. 5(30). 6049–6057. 48 indexed citations

14.

Caster, Joseph M., Stephanie Yu, Samuel B. Warner, et al.. (2017). Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy. Nanomedicine Nanotechnology Biology and Medicine. 13(5). 1673–1683. 88 indexed citations

15.

Min, Yuanzeng, Kyle C. Roche, Shaomin Tian, et al.. (2017). Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nature Nanotechnology. 12(9). 877–882. 590 indexed citations breakdown →

16.

Tian, Xi, Minh Nguyen, Henry P. Foote, et al.. (2016). CRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α. Cancer Research. 77(1). 112–122. 72 indexed citations

17.

Tian, Jing, Zachary L. Rodgers, Xiaomeng Wan, et al.. (2016). Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer. Nanomedicine Nanotechnology Biology and Medicine. 13(3). 1301–1307. 23 indexed citations

18.

Roche, Kyle C., et al.. (2015). SOX9 Maintains Reserve Stem Cells and Preserves Radioresistance in Mouse Small Intestine. Gastroenterology. 149(6). 1553–1563.e10. 125 indexed citations

19.

Gracz, Adam D., Ian Williamson, Kyle C. Roche, et al.. (2015). A high-throughput platform for stem cell niche co-cultures and downstream gene expression analysis. Nature Cell Biology. 17(3). 340–349. 111 indexed citations

20.

Roche, Kyle C., et al.. (2015). 800b Sox9 Maintains Reserve Stem Cells in Mouse Small Intestine. Gastroenterology. 148(4). S–1191. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact